期刊名称：EUROPEAN THYROID JOURNAL
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Official Journal of the European Thyroid Association
The international journal for basic, translational and clinical thyroidology
Aims and Scope
The European Thyroid Journal publishes papers reporting original research in basic, translational and clinical thyroidology. Original contributions cover all aspects of the field, from molecular and cellular biology to immunology and biochemistry, from physiology to pathology, and from pediatric to adult thyroid diseases with a special focus on thyroid cancer. Readers also benefit from reviews by noted experts, which highlight especially active areas of current research. The journal will further publish formal guidelines in the field, produced and endorsed by the European Thyroid Association.
Bibliographic Details
European Thyroid Journal
Journal Abbreviation: Eur Thyroid J
ISSN: 2235-0640 (Print)
e-ISSN: 2235-0802 (Online)
DOI: 10.1159/issn.2235-0640
www.karger.com/ETJ
Indexing/Abstracting
Listed in bibliographic services, including:
PubMed | US National Library of Medicine
PubMed Central | US National Library of Medicine
Web of Science | Clarivate Analytics
Science Citation Index | Clarivate Analytics
Science Citation Index Expanded | Clarivate Analytics
Current Contents - Clinical Medicine | Clarivate Analytics
Emerging Sources Citation Index | Clarivate Analytics
Google Scholar | Google
Chemical Abstracts Service | American Chemical Society
Embase | Elsevier
Pathway Studio | Elsevier
WorldCat | OCLC
Instructions to Authors
Article Types
Research Articles
Research Articles report on primary research. They must describe significant and original observations. Consideration for publication is based on the article’s originality, novelty, and scientific soundness, and the appropriateness of its analysis.
Research Articles are reports of original work. Authors are asked to follow the EQUATOR Network for Research Articles.
Prior approval from an Institutional Review Board (IRB) or an Ethics Review Committee is required for all investigations involving human subjects.
More information is available in the downloadable Research Article sample below.
Documents
Research Article (DOC, 48.5 KB)
Manuscripts should contain a maximum of 2,500 words, 40 references, plus tables/figures.
Review Articles
Review Articles are considered reviews of research or summary articles. They are state-of-the-art papers covering a current topic by experts in the field. They should give evidence on and provide answers to a well-defined aspect or question in a particular area. Review Articles must include a critical discussion of the reported data and give a clear conclusion with potential impacts on the standard of care.
More information is available in the downloadable Review Article sample below.
Documents
Review Article (DOC, 43.5 KB)
Manuscripts should contain a maximum of 3,500 words, 75 references, plus tables/figures.
Case ReportsCase Reports can present a case study, case report, or other description of a case. Case Reports present significant new insights or cases with an unusual and noteworthy course.
Submissions can be based on a case or a number of similar cases. The most important aspect of the presentation is that it should provide a new perspective on a recognized clinical scenario or may represent an entirely new clinical condition. The novelty of the case(s) may lie in the phenotype, the presentation, the investigation, and/or the management. We strongly encourage authors to comply with the CARE guidelines, as well as obtaining written consent from the subject(s) of your case report if you plan to include any photographs or images of them in your manuscript. More information is available in the downloadable Case Report sample below.
Documents
Novel Insights (DOC, 49 KB)
Authors may wish to submit the following Case Report:
Novel Insights: This Case Report is to include highlighted boxes containing one or two bullet points on 'Established Facts' (what is already known) and 'Novel Insights' (what new information has been gained). These should be selected so as to reinforce the novelty of the clinical observation.
Editorials
Editorials are discussions related to a specific article or issue written by an editor or other member of the publication staff.
More information is available in the downloadable Editorial sample below.
Documents
Editorial (DOC, 38.5 KB)
Editorials are usually invited by the Editor-in-Chief.
Letters
Letters are encouraged if they directly concern articles recently published in the journal. If accepted, the editors reserve the right to submit such letters to the authors of the articles concerned prior to publication, in order to permit them to respond in the same issue of the journal.
In exceptional cases, Letters may also address data published in another journal or general subjects related to matters discussed in the journal.
More information is available in the downloadable Letter sample below.
Documents
Letter (DOC, 37 KB)
Manuscripts should contain a maximum of 1,200 words and 10 references.
Contact InformationShould you have any problems with your submission, please contact the editorial office:
Esther Bettiol
Editorial Office 'European Thyroid Journal'
S. Karger AG
P.O. Box
CH-4009 Basel (Switzerland)
Tel. +41 61 306 1361
Fax. +41 61 306 1434
etj@karger.com
Conditions
General ConditionsOnly papers written in English are considered. The articles should be comprehensible to a reader who is fluent in English and should be edited prior to submission to ensure that standard English grammar and usage are observed. Use of a professional language editing service prior to submission can help avoid delays with the review process.
All manuscripts are subject to editorial review.
The presentation of manuscripts should follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals from the International Committee of Medical Journal Editors (ICMJE).
Karger journals aim to adhere to the COPE Code of Conduct and Best Practice Guidelines.
By submitting an article for publication, the authors agree to the transfer of the copyright to the owner of the journal, the European Thyroid Association, upon acceptance. Accepted papers become the permanent property of the Journal and may not be reproduced by any means, in whole or in part, without the written consent of the publisher.
The Submission Statement with original (hand-written) signatures is to be provided upon submitting the paper. If it is not possible to collect all signatures on a single document, individual copies should be provided for each author. Manuscripts may be accompanied by a cover letter in addition to the Submission Statement if additional information is to be communicated to the Editor(s)-in-Chief.
It is the authors’ responsibility to obtain permission to reproduce illustrations, tables, etc., from other publications.
StatementsAll submitted manuscripts must contain a Statement of Ethics and a Disclosure Statement after the main body of the text, but before the reference list. More information on statements can be found in the article samples downloadable in the Article Types section.
PlagiarismWhether intentional or not, plagiarism is a serious offense. If evidence of plagiarism is found before or after acceptance, or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are found to be unsatisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s).
Peer Review
European Thyroid Journal is a peer-reviewed journal that uses a single-blind peer review system. Our aim is to provide authors with timely and constructive feedback regarding their submitted manuscript. The Editor(s)-in-Chief and the internationaleditorial board ensure a thorough and fair peer review process and the highestscientific publishing standards. Editors guide the peer review process for papers in their areas of expertise.
During online submission, you may be asked to provide the contact details, including e-mail addresses, of potential reviewers of your paper. Reviewers must have a recent publication record in the area of the submitted paper, must not have published with the authors in the previous three years, and must not be from the same institution as the authors.
The Editor(s)-in-Chief is/are responsible for maintaining a high-quality peer review of papers submitted to the journal. Their decision concerning the acceptance or rejection of submitted manuscripts is final.
Article Preparation
Formatting
The preferred word processing program for manuscripts is Microsoft Word. Page and line numbering should be activated, and subtitles within the document should be numbered for clarity.
Footnotes should be avoided. When essential, they should be numbered consecutively and appear at the foot of the appropriate page.
Abbreviations (with the exception of those clearly well established in the field) should be explained when they are first used both in the abstract and in the main text.
Units of measurement should be expressed in SI units wherever possible.
Generic names of drugs (first letter: lowercase) should be used whenever possible. Registered trade names (first letter: uppercase) should be marked with the superscript registration symbol ® or ™ when they are first mentioned.
The manuscript, tables, figures, and submission statement must be submitted in separate files.
For further technical specifications, including those regarding tables, figures, and illustrations, please refer to the Karger website.
Manuscript Arrangement
Title Page
The first page should contain a short and concise title plus a running head of no more than 80 characters. Abbreviations should be avoided.
Below the title, list all the authors’ names as outlined in the article sample, which can be downloaded under Article Types. Each listed author must have an affiliation, which comprises the department, university, or organization and its location, city, state/province (if applicable), and country.
Place the full postal address of the corresponding author at the bottom of the first page, including at least one telephone number and e-mail address.
Keywords relevant to the article should be listed below the corresponding author information.
BodyPlease refer to the Article Types section of the Guidelines for Authors for information on the relevant article structure, including maximum word counts and downloadable samples.
Online Supplementary MaterialOnline Supplementary Material may be used to enhance a publication and increase its visibility on the Web. Supplementary files (directly relevant but not essential to the conclusions of the paper) will undergo editorial review and should be submitted in a separate file with the original manuscript and with all subsequent submissions. The Editor(s) reserve(s) the right to limit the scope and length of supplementary material. Supplementary material must meet production quality standards for publication without the need for any modification or editing and should not exceed 10 Mb in size. Figures and tables must have titles and legends, and all files must be supplied separately and named clearly. Acceptable files and formats are Word or PDF files, Excel spreadsheets (if the data cannot be converted properly into a PDF file), and multimedia files (MPEG, AVI, or QuickTime formats). All supplementary material should be referred to in the main text. A DOI number will be assigned to supplementary material, and it will be hosted online at https://karger.figshare.comunder a CC BY license. Supplementary material may incur a charge. See Cost of Publication for more information.
References
In-Text Citation
References in the text should be identified using Arabic numerals [in square brackets].
The reference list should not be alphabetized, but the references should be numbered consecutively in the order in which they are first mentioned in the text. Material submitted for publication but not yet accepted should be noted as ‘unpublished data’ and may not be included in the reference list.
Further information and examples can be found in the downloadable article samples in Article Types. If you are using reference management software, we recommend using the Vancouver Referencing Style.
Reference Management SoftwareThe use of EndNote is recommended to facilitate formatting of citations and reference lists. The journal output style can be downloaded from http://endnote.com/downloads/styles.
Author Services
Karger Publishers offer a range of services to assist authors with the preparation of their manuscript, including discounts for language editing services offered by third parties.
More information is available on the Author Resources section of the Karger homepage.
When submitting a manuscript, authors can add their ORCID number to their Karger account to ensure that their paper is accredited to them correctly.
Cost of Publication
Page Charges/Article Processing Charges
Charges are waived in this journal, meaning publication is free of charge.
Online Supplementary MaterialThere are no additional fees for hosting supplementary material.
Illustration ChargesThere is no charge for figures appearing in grayscale. Color illustrations are charged to the author at CHF 960.00 / USD 1,130.00 / EUR 960.00 per page.
Author's ChoiceKarger Publisher’s Author’s Choice™ service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading, and printing at www.karger.com. The option is available for a one-time fee, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice. For a fee of CHF 3,000.00 / USD 3,530.00 / EUR 3,000.00, the final, published version of the article may be posted at any time and in any repository or on other websites, in accordance with the relevant Creative Commons license as well as the current Karger self-archiving policy for Open Access articles. Karger supplies all articles to PubMed Central for indexing.
Journal Policies
Copyediting and ProofsManuscripts accepted for publication by Karger Publishers are subject to copyediting. Karger Publishers’ house style is based on internationally recognized standard manuals, including The Chicago Manual of Style.
An e-mail containing a link to download the RTF proofs will be sent to the corresponding author. The authors should check the RTF document and respond to any questions that have been raised during proofreading within 48 hours. Only text corrections are required, since layout and typesetting take place at a later stage.
Alterations made to proofs, other than the correction of errors introduced by the Publisher, are charged to the authors and may require editorial approval.
Please note that the revised proofs are not sent to the authors prior to typesetting and online publication unless there are exceptional circumstances. The article layout will be created according to the Karger standard.
DOI NumberA DOI number will be available as a unique identifier on the title page of each article. DOIs are useful for identifying and citing articles published online without volume or issue information (for more information, see www.doi.org).
Online First PublicationAll articles are published electronically ahead of print with a DOI number and are supplemented later with the definite reference to the printed version. The articles become available immediately after the authors’ approval to print.
Licenses and CopyrightThe Submission Statement outlines the licensing and copyright terms. A copy of the Submission Statement originally hand signed by all authors must be received by the editorial office. Please print and sign the form, and upload it during submission to make it legally binding. A brief cover letter may also be included if additional information is to be communicated to the Editor(s)-in-Chief.
Self-Archiving
Karger permits authors to archive their preprints (i.e., before peer review) or postprints (i.e., accepted manuscripts after peer review but before production) on their personal home page or institution’s repository, provided that these are not used for commercial purposes, are linked to the publisher’s version, and acknowledge the publisher’s copyright.
In addition, authors may post their accepted manuscripts in public Open Access repositories and scientific networks no earlier than 12 months following publication of the final version of their article. For all self-archiving, the posted manuscripts must:
1. Be used for noncommercial purposes only
2. Not be published or posted on any repository or website under a Digital Object Identifier (DOI) that differs from the DOI of the final version published by Karger.
3. Be linked to the final version on www.karger.com and include one of the following statements, as appropriate:
"This is the peer-reviewed but unedited manuscript version of the following article: [insert full citation, e.g., Cytogenet Genome Res
2014;142:227–238 (DOI: 10.1159/000361001)]. The final, published version is available at http://www.karger.com/?doi=[insert DOI
number]."
OR
"This is the un-reviewed and unedited manuscript version of the following article: [insert full citation, e.g., Cytogenet Genome Res 2014;142:227–238 (DOI: 10.1159/000361001)]. The final, published version is available at http://www.karger.com/?doi=[insert DOI number]."
It is the authors’ responsibility to fulfill these requirements.
For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.
Manuscripts to be archived in PubMed Central due to funding requirements or that have been published under the Author’s
Choice™ scheme will be submitted by Karger on the authors’ behalf, as outlined under Funding Organizations.
Funding OrganizationsIf the authors are affiliated with an organization that has an offsetting agreement with Karger Publishers which may allow them to publish their article free of charge, this should be communicated in a cover letter at the submission stage, so that eligibility can be assessed.
NIH-Funded Research
The US National Institutes of Health (NIH) Public Access Policy mandates that final, peer-reviewed manuscripts are archived in its digital database PubMed Central (PMC) within 12 months of the official publication date. As a service to authors, Karger Publishers submits the accepted, unedited version of NIH-funded manuscripts to PMC upon publication. The final, peer-reviewed article is made available after a 12-month embargo period. Where the authors have chosen to make their paper freely available under Karger’s *Author’s Choice™*37 service, this embargo does not apply.
Other Funding Sources
Karger Publishers also complies with other funders’ requirements (including the Wellcome Trust and RCUK) for submission to PMC. Authors should include information on their grants in the Funding Sources section of their papers.
More information on funding sources can be found on the Karger website.
Submission
Manuscript Submission
Manuscripts should be submitted online via the European Thyroid Journal submission portal.
Before submission, please read the Guidelines for Authors for specific requirements for manuscript preparation.
Submission StatementA Submission Statement, downloadable below, signed by all authors must be received by the editorial office. Please print and sign the form, and upload it during submission to make it legally binding. A brief cover letter outlining in how far the work is interdisciplinary and what is new in regard to the current literature on the topic may be included, but this is not essential.
Documents
Submission Statement ETJ (PDF, 172.57 KB)
Editorial Board
Editor-in-Chief
Wilmar M. Wiersinga – Academic Medical Center, Amsterdam, Netherlands
Associate Editors
Rosella Elisei – University of Pisa, Pisa, Italy (Thyroid Cancer)
Jens Mittag – University of Lübeck, Lübeck, Germany (Basic Thyroidology)
Furio Pacini – University of Siena, Siena, Italy (Thyroid Cancer)
Simon Pearce – Newcastle University, Newcastle-upon-Tyne, UK (Clinical Thyroidology)
Luca Persani – University of Milan, Milan, Italy (Translational Thyroidology)
Editorial Board
Rebecca Bahn – Mayo Medical School, Rochester, MN, USA
Paul Banga – King’s College London School of Medicine, London, UK
Luigi Bartalena – University of Insubria, Varese, Italy
Bernadette Biondi – University of Naples Federico II, Naples, Italy
Anita Boelen – Academic Medical Center, Amsterdam, Netherlands
Steen Bonnema – Odense University Hospital, Odense, Denmark
Georg Brabant – University of Lübeck, Lübeck, Germany
Monica Dentice – University of Naples, Naples, Italy
Creswell Eastman – The University of Sydney, Westmead, NSW, Australia
Grigoris Effraimidis – Rigshospitalet, Copenhagen, Denmark
Murat Erdogan – Ibni-i-Sina Hastanesi, Ankara, Turkey
Valentin Fadeyev – Federal Endocrinological Scientific Centre, Moscow, Russia
Ulla Feldt-Rasmussen – Copenhagen Univ. Hosp., Rigshospitalet, Copenhagen, Denmark
Dagmar Führer-Sakel – University Hospital Essen, Essen, Germany
George Kahaly – Gutenberg University Medical Center, Mainz, Germany
Gerd Krause – Leibniz-Institut für Molekulare Pharmakologie (FMP), Berlin, Germany
Rui Maciel – Universidade Federal de São Paulo, São Paulo, Brazil
Ana Luiza Maia – Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
Ralf Paschke – University of Calgary, Calgary, AB, Canada
Agnieszka Piekielko-Witkowska – The Medical Centre of Postgraduate Education,Warsaw, Poland
Kris Poppe – CHU St-Pierre (ULB), Brussels, Belgium
Samuel Refetoff – University of Chicago, Chicago, IL, USA
Jacques Samarut – ENS de Lyon, Lyon, France
Pilar Santisteban – Instituto de Investigaciones Biomedicas CSIC-UAM, Madrid, Spain
YoungKee Shong – Asan Medical Center, Seoul, South Korea
Peter Taylor – Cardiff University School of Medicine, Cardiff, UK
Weiping Teng – The First Hospital of China, Medical University, Shenyang, China
Edward Visser – Erasmus Medical Center, Rotterdam, Netherlands
Paolo Vitti – University of Pisa, Pisa, Italy
Shunichi Yamashita – Nagasaki University, Nagasaki, Japan
|
